Presentation TCT 2025 INCORPORATE-EXTENDED: Two-Center Long-Term Outcomes of an Intentional Invasive vs Conservative Coronary Strategy After Critical Limb Ischemia Revascularization Presenter: Sadeek Sidney Kanoun Schnur October 26, 2025
Presentation TCT 2025 TCT 773: Efficacy and Clinical outcomes of Human Hepatocyte Growth Factor(HHGF) Plasmid in Critical Limb Ischemia(CLI): A Systematic Review and Meta Analysis Presenter: Ananya Prasad October 26, 2025
News Conference News THT 2025 Experts Hash Out Recommendations for Impella CP After DanGer Shock Todd Neale February 14, 2025
News Conference News VIVA 2024 Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK L.A. McKeown November 05, 2024
News Conference News TCT 2024 Bleeding After MCS in DanGer Shock: When, Where, and What to Do? Caitlin E. Cox October 31, 2024
Presentation TCT 2024 TCT 1373: Treatment of Critical Limb Ischemia in Severe Aortic Stenosis Presenter: Zoltan Ruzsa October 28, 2024
Presentation TCT 2024 TCT 394: Peripheral Bioresorbable Scaffold Made by Multi-Axial Extrusion Technology: New Material, Design and First-in-Human Experience Presenter: Yuxian Luo October 27, 2024
Presentation TCT 2024 TCT 397: Comparative Outcomes of Below-the-Knee CTO vs Non-CTO Peripheral Artery Interventions From the XLPAD Registr Presenter: Minseob Jeong October 27, 2024
Presentation TCT 2024 TCT 396: Outcomes of Below the Knee Chronic Total Occlusions Interventions: Insights From the XLPAD Registry Presenter: Deepakraj Gajanana October 27, 2024
Presentation TCT 2024 TCT 395: Differences in Outcomes Between Rutherford 4 and Rutherford 5/6 Patients Undergoing Endovascular Intervention for Lower Extremity Peripheral Artery Disease Presenter: Daniel Snyder October 27, 2024
Presentation TCT 2024 TCT 30: Comparative Outcomes of Non-Stent Below-the-Knee Peripheral Artery Interventions in Critical Limb Threatening Ischemia vs Intermittent Claudication From the XLPAD Registry Presenter: Minseob Jeong October 27, 2024
Presentation TCT 2024 TCT 26: Pharmacokinetic Profile of Everolimus Eluted From the Esprit BTK Scaffold: Data From the LIFE-BTK Pharmacokinetics Sub-Study Presenter: Richard Pin October 27, 2024
Presentation TCT 2024 TCT 29: The Changing Landscape of Treatment Setting for Chronic Limb Threatening Ischemia Among Medicare Beneficiaries Presenter: Joseph Kim October 27, 2024
Presentation TCT 2024 TCT 28: Target Vessel Revascularization and Amputation After Chronic Limb-Threatening Ischemia Across Race Among Medicare Beneficiaries Presenter: Joseph Kim October 27, 2024
Presentation TCT 2024 TCT 27: Pre-Clinical Data on a Novel Hybrid Drug-Eluting Stent With Nanocoating for Below-the-Knee Lesions: “Leave the Right Thing Behind” Presenter: Emi Kearon October 27, 2024
Presentation TCT 2024 TCT 25: Endovascular Intervention Versus Bypass Surgery in the Treatment of Chronic Limb-Threatening Ischemia: A Meta-Analysis of Randomized Control Trials Presenter: Shadi Halabi October 27, 2024
News Daily News New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients L.A. McKeown August 19, 2024
News Conference News ISET 2024 How to Reconcile BEST-CLI and BASIL-2? A ‘Patient-First’ Strategy Caitlin E. Cox January 24, 2024
Presentation TCT 2023 Intentional Coronary Revascularization Versus Conservative Therapy in Patients, who Underwent Successful Peripheral Artery Revascularization due to Critical Limb Ischemia - the INCORPORATE Randomized Clinical Trial Presenter: Gabor Toth October 25, 2023
Presentation TCT 2023 TCT 308: Demographic, Ethnic, and Geographic Trends of Amputations in Critical Limb Ischemia: 2008-2020 Presenter: Shafaqat Ali October 24, 2023